InsiderTrades

Form 4 for SNPS Synopsys

Accepted 2024-06-12 00:00:00 ET · period of report 2024-06-10 · accession 0001517737-24-000071 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-06-12 2024-06-10 SNPS RUNKEL JOHN F JR GC, Corp. Sec M - OptEx $281.21 +936 20.6K +5% +$263.2K
DM 2024-06-12 2024-06-10 SNPS RUNKEL JOHN F JR GC, Corp. Sec S - Sale+OE $566.97 -936 20.0K -4% -$530.7K
DM 2024-06-12 2024-06-10 SNPS RUNKEL JOHN F JR GC, Corp. Sec M - OptEx $0.00 -936 1,139 -45% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-06-10 M A 366 $354.48 20,366 D — —
2 Common Common Stock 2024-06-10 S D 570 $566.97 20,000 D — —
3 Common Common Stock 2024-06-10 M A 570 $234.17 20,570 D — —
4 Common Common Stock 2024-06-10 S D 366 $566.97 20,000 D — —
5 Derivative Non-Qualified Stock Option (right to buy) 2024-06-10 M D 366 $0.00 2,197 D $354.48 · 2022-12-09 to 2028-12-09 366 Common Stock (F2) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
6 Derivative Non-Qualified Stock Option (right to buy) 2024-06-10 M D 570 $0.00 1,139 D $234.17 · 2021-12-10 to 2027-12-10 570 Common Stock (F2) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.